3 Good Reasons To Adopt Decentralized Clinical Trials

The clinical trials industry has been facing numerous and long-lasting challenges of patient recruitment and retention, patient compliance, and clinical trial inefficiency. This has led to a considerable transformation of clinical trials, which has been further accelerated by the COVID-19 pandemic. But why has the decentralization of clinical trials become a ‘must have’? Find out in the available article.

To learn more about Kayentis, visit their Clinical Leader page.